Suprapubic Versus Transurethral Catheterization After Rectal Resection With Low Anastomosis for Cancer in Males

NCT ID: NCT02922647

Last Updated: 2022-07-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

240 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-10-14

Study Completion Date

2021-04-16

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to compare the urinary tract infection rate on the four postoperative day between the 2 groups of patients who have undergone total mesorectal excision for cancer and low anastomosis, with either suprapubic or transurethral catheterization.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Infection Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

suprapubic catheterization

Intervention:suprapubic catheterization after rectal resection with low anastomosis. Evaluate the urinary tract infection rate on the four days postoperative.

Group Type EXPERIMENTAL

suprapubic catheterization

Intervention Type DEVICE

Experimental Arm: Suprapubic catheterization after rectal resection with low anastomosis for cancer in males

transurethral catheterization

Intervention:transurethral catheterization after rectal resection with low anastomosis. Evaluate the urinary tract infection rate on the four days postoperative.

Group Type ACTIVE_COMPARATOR

transurethral catheterization

Intervention Type DEVICE

Active comparator: Transurethral catheterization after rectal resection with low anastomosis for cancer in males

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

suprapubic catheterization

Experimental Arm: Suprapubic catheterization after rectal resection with low anastomosis for cancer in males

Intervention Type DEVICE

transurethral catheterization

Active comparator: Transurethral catheterization after rectal resection with low anastomosis for cancer in males

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male patients of at least 18 years of age
* Histologically proven rectal adenocarcinoma
* Stage T1-4 Nx Mx
* With or without neoadjuvant treatment
* TME and low anastomosis (colorectal or coloanal, stapled or handsewn)
* With or without loop ileostomy
* Open or laparoscopic approach
* Patient and doctor have signed a study specific informed consent form

Exclusion Criteria

* Colonic and upper third rectal cancer (No or Partial Mesorectal Excision)
* Abdominoperineal resection
* Associated prostate, and/or seminal glands and/or bladder resection
* Infected tumour, Emergency surgery
* Epidural analgesia
* Patient with antibiotic therapy (other than prophylaxis)
* Previous treated/untreated known prostate or bladder carcinoma
* Patient with symptomatic preoperative voiding dysfunction (IPSS score \>19)
* Medical history of bladder catheterization for obstruction, or urethral surgery
* Patient necessitating urinary output monitoring (impaired renal function etc)
* Patient deprived of liberty or under guardianship or incapable of giving consent
* Against the usual indications of suprapubic drainage and / or urethral sounding any known allergies to medical device materials. (p. ex. latex) and in general the known allergies to sterilizing agents (particularly oxide ethylene and its derivatives.
Minimum Eligible Age

18 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Grenoble

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Pr Jean Luc FAUCHERON

Role: PRINCIPAL_INVESTIGATOR

University Clinic of Digestive Surgery and Emergency

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Hospital Grenoble

Grenoble, Auvergne-Rhône-Alpes, France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

References

Explore related publications, articles, or registry entries linked to this study.

Shah EF, Huddy SP. A prospective study of genito-urinary dysfunction after surgery for colorectal cancer. Colorectal Dis. 2001 Mar;3(2):122-5. doi: 10.1046/j.1463-1318.2001.00221.x.

Reference Type BACKGROUND
PMID: 12791005 (View on PubMed)

Sterk P, Shekarriz B, Gunter S, Nolde J, Keller R, Bruch HP, Shekarriz H. Voiding and sexual dysfunction after deep rectal resection and total mesorectal excision: prospective study on 52 patients. Int J Colorectal Dis. 2005 Sep;20(5):423-7. doi: 10.1007/s00384-004-0711-4. Epub 2005 Apr 22.

Reference Type BACKGROUND
PMID: 15846498 (View on PubMed)

Branagan GW, Moran BJ. Published evidence favors the use of suprapubic catheters in pelvic colorectal surgery. Dis Colon Rectum. 2002 Aug;45(8):1104-8. doi: 10.1007/s10350-004-6368-9.

Reference Type BACKGROUND
PMID: 12195198 (View on PubMed)

Lee SY, Kang SB, Kim DW, Oh HK, Ihn MH. Risk factors and preventive measures for acute urinary retention after rectal cancer surgery. World J Surg. 2015 Jan;39(1):275-82. doi: 10.1007/s00268-014-2767-9.

Reference Type BACKGROUND
PMID: 25189452 (View on PubMed)

Platt R, Polk BF, Murdock B, Rosner B. Mortality associated with nosocomial urinary-tract infection. N Engl J Med. 1982 Sep 9;307(11):637-42. doi: 10.1056/NEJM198209093071101.

Reference Type BACKGROUND
PMID: 7110215 (View on PubMed)

Tambyah PA, Oon J. Catheter-associated urinary tract infection. Curr Opin Infect Dis. 2012 Aug;25(4):365-70. doi: 10.1097/QCO.0b013e32835565cc.

Reference Type BACKGROUND
PMID: 22691687 (View on PubMed)

Rasmussen OV, Korner B, Moller-Sorensen P, Kronborg O. Suprapubic versus urethral bladder drainage following surgery for rectal cancer. Acta Chir Scand. 1977;143(6):371-4. No abstract available.

Reference Type BACKGROUND
PMID: 605738 (View on PubMed)

Shapiro J, Hoffmann J, Jersky J. A comparison of suprapubic and transurethral drainage for postoperative urinary retention in general surgical patients. Acta Chir Scand. 1982;148(4):323-7.

Reference Type BACKGROUND
PMID: 7136436 (View on PubMed)

Sethia KK, Selkon JB, Berry AR, Turner CM, Kettlewell MG, Gough MH. Prospective randomized controlled trial of urethral versus suprapubic catheterization. Br J Surg. 1987 Jul;74(7):624-5. doi: 10.1002/bjs.1800740731.

Reference Type BACKGROUND
PMID: 3304522 (View on PubMed)

Piergiovanni M, Tschantz P. [Urinary catheterization: transurethral or suprapubic approach?]. Helv Chir Acta. 1991 Jul;58(1-2):201-5. French.

Reference Type BACKGROUND
PMID: 1938446 (View on PubMed)

O'Kelly TJ, Mathew A, Ross S, Munro A. Optimum method for urinary drainage in major abdominal surgery: a prospective randomized trial of suprapubic versus urethral catheterization. Br J Surg. 1995 Oct;82(10):1367-8. doi: 10.1002/bjs.1800821024.

Reference Type BACKGROUND
PMID: 7489167 (View on PubMed)

Ratnaval CD, Renwick P, Farouk R, Monson JR, Lee PW. Suprapubic versus transurethral catheterisation of males undergoing pelvic colorectal surgery. Int J Colorectal Dis. 1996;11(4):177-9. doi: 10.1007/s003840050038.

Reference Type BACKGROUND
PMID: 8876274 (View on PubMed)

Perrin LC, Penfold C, McLeish A. A prospective randomized controlled trial comparing suprapubic with urethral catheterization in rectal surgery. Aust N Z J Surg. 1997 Aug;67(8):554-6. doi: 10.1111/j.1445-2197.1997.tb02037.x.

Reference Type BACKGROUND
PMID: 9287924 (View on PubMed)

Baan AH, Vermeulen H, van der Meulen J, Bossuyt P, Olszyna D, Gouma DJ. The effect of suprapubic catheterization versus transurethral catheterization after abdominal surgery on urinary tract infection: a randomized controlled trial. Dig Surg. 2003;20(4):290-5. doi: 10.1159/000071693. Epub 2003 Jun 5.

Reference Type BACKGROUND
PMID: 12789024 (View on PubMed)

McPhail MJ, Abu-Hilal M, Johnson CD. A meta-analysis comparing suprapubic and transurethral catheterization for bladder drainage after abdominal surgery. Br J Surg. 2006 Sep;93(9):1038-44. doi: 10.1002/bjs.5424.

Reference Type BACKGROUND
PMID: 16804872 (View on PubMed)

Niel-Weise BS, van den Broek PJ. Urinary catheter policies for short-term bladder drainage in adults. Cochrane Database Syst Rev. 2005 Jul 20;(3):CD004203. doi: 10.1002/14651858.CD004203.pub2.

Reference Type BACKGROUND
PMID: 16034924 (View on PubMed)

Healy EF, Walsh CA, Cotter AM, Walsh SR. Suprapubic compared with transurethral bladder catheterization for gynecologic surgery: a systematic review and meta-analysis. Obstet Gynecol. 2012 Sep;120(3):678-87. doi: 10.1097/AOG.0b013e3182657f0d.

Reference Type BACKGROUND
PMID: 22914481 (View on PubMed)

Trilling B, Tidadini F, Lakkis Z, Jafari M, Germain A, Rullier E, Lefevre J, Tuech JJ, Kartheuser A, Leonard D, Prudhomme M, Piessen G, Regimbeau JM, Cotte E, Duprez D, Badic B, Panis Y, Rivoire M, Meunier B, Portier G, Bosson JL, Vilotitch A, Foote A, Caspar Y, Rouanet P, Faucheron JL; GRECCAR study Group. Suprapubic versus transurethral catheterization for bladder drainage in male rectal cancer surgery (GRECCAR10), a randomized clinical trial. Tech Coloproctol. 2024 Jul 2;28(1):77. doi: 10.1007/s10151-024-02950-2.

Reference Type DERIVED
PMID: 38954131 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

38RC14.457

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.